Liu Wei, Zhang Yue, Yu Cheuk-Man, Ji Qing-Wei, Cai Meng, Zhao Ying-Xin, Zhou Yu-Jie
Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China.
School of Public Health, Capital Medical University, Beijing, China.
J Geriatr Cardiol. 2015 Nov;12(6):668-75. doi: 10.11909/j.issn.1671-5411.2015.06.012.
Coronary artery calcification (CAC) is highly prevalent in patients with coronary heart disease (CHD) and is associated with major adverse cardiovascular events. There are two recognized type of CAC-intimal and medial calcification, and each of them have specific risk factors. Several theories about the mechanism of vascular calcification have been put forward, and we currently believe that vascular calcification is an active, regulated process. CAC can usually be found in patients with severe CHD, and this asymptomatic phenomenon make early diagnosis of CAC important. Coronary computed tomographic angiography is the main noninvasive tool to detect calcified lesions. Measurement of coronary artery calcification by scoring is a reasonable metric for cardiovascular risk assessment in asymptomatic adults at intermediate risk. To date, effective medical treatment of CAC has not been identified. Several strategies of percutaneous coronary intervention have been applied to CHD patients with CAC, but with unsatisfactory results. Prognosis of CAC is still a major problem of CHD patients. Thus, more details about the mechanisms of CAC need to be elucidated in order to improve the understanding and treatment of CAC.
冠状动脉钙化(CAC)在冠心病(CHD)患者中非常普遍,并且与主要不良心血管事件相关。有两种公认的CAC类型——内膜钙化和中膜钙化,它们各自具有特定的危险因素。关于血管钙化机制已经提出了几种理论,目前我们认为血管钙化是一个活跃的、受调控的过程。CAC通常可在重度CHD患者中发现,而这种无症状现象使得CAC的早期诊断很重要。冠状动脉计算机断层血管造影是检测钙化病变的主要非侵入性工具。通过评分来测量冠状动脉钙化是对中度风险无症状成年人进行心血管风险评估的合理指标。迄今为止,尚未确定针对CAC的有效药物治疗方法。几种经皮冠状动脉介入治疗策略已应用于患有CAC的CHD患者,但效果并不理想。CAC的预后仍然是CHD患者的一个主要问题。因此,需要阐明更多关于CAC机制的细节,以增进对CAC的理解并改善其治疗。